IP Library Granted Patent US 10,588,748
Granted Patent B2
US 10,588,748 · App. 15/040,075 · Granted Mar 17, 2020

Device to fill a bone void whilst minimising pressurisation

Inventors: John Warren Colclough (Keele, GB); Phillip Anthony Laycock (Keele, GB); John Joseph Cooper (Keele, GB); Russell David Waters (Keele, GB)
Assignee: BIOCOMPOSITES LIMITED
A61F2/28A61B17/68A61B17/7094A61B17/72A61B17/921A61F2/4644B29C39/026B29C64/00A61F2002/2835B29L2031/7532B33Y10/00B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,588,748
App. No.
15/040,075
Granted
Mar 17, 2020
Kind
B2
Abstract

Disclosed is a device for implantation into a bone void while minimising the potential for an increase in pressure within the bone void.

Claims (16)

1. An implantable device for insertion into a bone void, the implantable device comprising a bone substitute material and having a cylindrical body and one or more longitudinal channels extending the entire length of the device, where said one or more longitudinal channels allows for depressurisation of the bone void during implantation of the device; the one or more longitudinal channels each intersecting a surface of the device and extending to an axial centerline thereof, and being tapered such that the width of the one or more longitudinal channels opening on an outer, circumferential edge of the implantable device is greater than its width at a base thereof; and wherein the devices have a flat surface on an opposing longitudinal side to the one or more longitudinal channels; and wherein the device has convex, domed or semispherical shaped ends.

2. An implantable device according to claim 1 , wherein the one or more longitudinal channels allows for the displacement and/or exit of the void contents.

3. An implantable device according to claim 1 , wherein the one or more longitudinal channels tapers in width from the exterior circumference towards its central axis.

4. An implantable device according to claim 3 , wherein the one or more longitudinal channels has a taper angle of 10 degrees to 145 degrees.

5. An implantable device according to claim 4 , wherein the taper angle of one or more longitudinal channels is from 20 degrees to 50 degrees.

6. An implantable device according to claim 1 , wherein an opposing surface to one or more longitudinal channels has a flat surface.

7. An implantable device according to claim 1 , wherein the device has a capsule shape, having one or more longitudinal channel intersecting the surface of the device and extending the full length of the device and also extending towards the device centreline.

8. An implantable device according to claim 1 , wherein the displacement of the void contents minimises an increase in pressure within the void.

9. An implantable device according to claim 1 , wherein the bone substitute material comprises a calcium-based bone substitute material.

10. An implantable device according to claim 1 , wherein the implantable device is adapted for insertion into a void that is within an intramedullary canal of a patient.

11. An implantable device according to claim 10 , wherein the implantable device is adapted for insertion into a void comprising a defect in bone.

12. An arrangement of two or more implantable devices comprising a plurality of the devices lined up end to end, wherein each of the implantable devices comprises a bone substitute material and has a cylindrical body and one or more longitudinal channels extending the entire length of the device, where said one or more longitudinal channels allows for depressurisation of the bone void during implantation of each device; the one or more longitudinal channels each intersecting a surface of each device and extending to an axial centerline thereof, and being tapered such that the width of the one or more longitudinal channels opening on an outer, circumferential edge of each implantable device is greater than its width at a base thereof; and wherein the devices have a flat surface on an opposing longitudinal side to the one or more longitudinal channels; and wherein each device has convex, domed or semispherical shaped ends.

13. An arrangement according to claim 12 , wherein the longitudinal channels are axially aligned with each other.

14. An arrangement according to claim 12 , wherein the longitudinal channels are not axially aligned with each other.

15. An arrangement according to claim 12 , wherein the arrangement is adapted for insertion into an intramedullary canal of a patient.

16. An implantable device according to claim 1 , wherein the one or more longitudinal channels extend the full length of the device.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2022
From: BARINGS FINANCE LLC
To: BIOCOMPOSITES LIMITED
Reel/Frame 060191/0602 →
SECURITY INTEREST Recorded Jun 1, 2017
From: BIOCOMPOSITES LIMITED
To: BARINGS FINANCE LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 042648/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: COLCLOUGH, JOHN WARREN; LAYCOCK, PHILLIP ANTHONY; COOPER, JOHN JOSEPH; WATERS, RUSSELL DAVID
To: BIOCOMPOSITES LIMITED
Reel/Frame 037709/0894 →
Priority Claims (1)
GB 1502655.2 · Feb 17, 2015 · national
Continuity (1)
Related Publication 20160235534A1 · Aug 18, 2016